Charles Goodwin | President and Chief Executive Officer |
Tara Semb | Chief Financial Officer |
Matt Hewitt | Craig-Hallum Capital Group |
Matthew O’Brien | Piper Sandler |
Kyle Bauser | Lake Street Capital Markets |
Dave Turkaly | JMP Securities |
Russell Cleveland | RENN Capital |
Hello and welcome, ladies and gentlemen to Third Quarter of 2022 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in listen-only mode. At the end of the company’s prepared remarks, we will conduct a question-and-answer session. Please note that this conference call is being recorded and that the recording will be available on the company’s website for replay shortly.
Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including without limitation to those identified in the risk factors section of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, our most recent 10-Q filing and the company’s other filings with the Securities and Exchange Commission.